Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis.

Details

Ressource 1Download: BIB_14B4AEA9711E.P001.pdf (6973.78 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_14B4AEA9711E
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis.
Journal
Plos One
Author(s)
Vala Ines Sofia, Martins Leila R., Imaizumi Natsuko, Nunes Raquel J., Rino Jose, Kuonen Francois, Carvalho Lara M., Ruegg Curzio, Grillo Isabel Monteiro, Barata Joao Taborda, Mareel Marc, Rosa Santos Susana Constantino
ISSN
1932-6203[electronic], 1932-6203[linking]
Publication state
Published
Issued date
2010
Volume
5
Number
6
Pages
11222
Language
english
Notes
epublish
Abstract
Radiotherapy is a widely used treatment option in cancer. However, recent evidence suggests that doses of ionizing radiation (IR) delivered inside the tumor target volume, during fractionated radiotherapy, can promote tumor invasion and metastasis. Furthermore, the tissues that surround the tumor area are also exposed to low doses of IR that are lower than those delivered inside the tumor mass, because external radiotherapy is delivered to the tumor through multiple radiation beams, in order to prevent damage of organs at risk. The biological effects of these low doses of IR on the healthy tissue surrounding the tumor area, and in particular on the vasculature remain largely to be determined. We found that doses of IR lower or equal to 0.8 Gy enhance endothelial cell migration without impinging on cell proliferation or survival. Moreover, we show that low-dose IR induces a rapid phosphorylation of several endothelial cell proteins, including the Vascular Endothelial Growth Factor (VEGF) Receptor-2 and induces VEGF production in hypoxia mimicking conditions. By activating the VEGF Receptor-2, low-dose IR enhances endothelial cell migration and prevents endothelial cell death promoted by an anti-angiogenic drug, bevacizumab. In addition, we observed that low-dose IR accelerates embryonic angiogenic sprouting during zebrafish development and promotes adult angiogenesis during zebrafish fin regeneration and in the murine Matrigel assay. Using murine experimental models of leukemia and orthotopic breast cancer, we show that low-dose IR promotes tumor growth and metastasis and that these effects were prevented by the administration of a VEGF receptor-tyrosine kinase inhibitor immediately before IR exposure. These findings demonstrate a new mechanism to the understanding of the potential pro-metastatic effect of IR and may provide a new rationale basis to the improvement of current radiotherapy protocols.
Keywords
Survival, Therapy, Radiotherapy, Recurrence, Apoptosis, VEGFR-2, Cells
Pubmed
Web of science
Open Access
Yes
Create date
12/07/2010 14:48
Last modification date
20/08/2019 12:43
Usage data